-
Start Preamble
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal in formation concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of person al privacy.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Clinical Coordinating Support for NIDA Center for Clinical Trials Network (CCTN) (2221).
Date: April 6, 2010.
Time: 9 a.m. to 2 p.m.
Agenda: To review and evaluate contract proposals.
Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, Rockville, MD 20850.
Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, (301) 435-1439, 1f33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Clinical Worlds: Enhancing Substance Abuse Provider Training Through Emerging Technologies (5544).
Date: April 27, 2010.
Time: 9:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852.
Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, (301) 435-1439, 1f33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Drug Scene Investigation Science (1138).
Date: April 28, 2010.
Time: 9:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852.
Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, (301) 435-1439, 1f33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)
Start SignatureDated: March 4, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-5171 Filed 3-10-10; 8:45 am]
BILLING CODE 4140-01-M
Document Information
- Effective Date:
- 4/6/2010
- Published:
- 03/11/2010
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2010-5171
- Dates:
- April 6, 2010.
- Pages:
- 11552-11552 (1 pages)
- PDF File:
- 2010-5171.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute